TAS::75 0849::tasvector biosafety testing mage-A3 vector supernatant item#26 assay#510011.BSV sterility
Ended Awarded
- Contract number
- HHSN26100005
- Awardee
-
Bioreliance Corporation UEI H3KAG9A26K77
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $32,797
Award facts
- Opportunity
-
- NIHCA2009015 Solicitation number
- Contract value 100% obligated
- $32,797.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Time and Materials
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Economy Act FAR subpart 17.5
Award details come from SAM.gov/FPDS.
About this award
This federal contract award, valued at $32,797.00, was issued by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Bioreliance Corporation through its Life Sciences Services Division. The contract is a Delivery Order with a Time and Materials pricing type, and the ultimate completion date is April 3, 2010.
The contract involves TAS::75 0849::TASVECTOR BIOSAFETY TESTING MAGE-A3 VECTOR SUPERNATANT ITEM#26 ASSAY#510011.BSV STERILITY services, which likely includes specialized testing and examination services to support the development of investigational new drugs and biologics. Bioreliance, a foreign-owned for-profit organization, provides a range of microbiological, bioburden, and safety testing services to various government agencies, including the National Institute of Allergy and Infectious Diseases (NIAID) and the Centers for Disease Control and Prevention (CDC). The contract does not have a set-aside designation, indicating Bioreliance's competitive standing in its field of expertise.
Quick answers
Who was awarded contract HHSN26100005?
HHSN26100005 was awarded to Bioreliance Corporation by National Cancer Institute (National Institutes of Health) on April 1, 2010.
How much is contract HHSN26100005 worth?
The government has obligated $32,797 on HHSN26100005.
Is contract HHSN26100005 an order under another contract?
Yes. HHSN26100005 is a delivery order under HHSN261200900022I, an indefinite delivery contract.
Was contract HHSN26100005 competed?
The extent of competition for HHSN26100005 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award